FDA Inspection 1304370 — Curexa - East, LLC dba Curexa
The FDA completed an inspection of Curexa - East, LLC dba Curexa on March 5, 2026 in Egg Harbor Township, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Egg Harbor Township, NJ (United States)